<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00161876</url>
  </required_header>
  <id_info>
    <org_study_id>213</org_study_id>
    <nct_id>NCT00161876</nct_id>
  </id_info>
  <brief_title>FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years</brief_title>
  <official_title>Open-label, Multicenter, Follow-up Phase III Study to Investigate the Safety of the Third Vaccination of FSME-IMMUN NEW in Volunteers Aged 16 to 66 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the safety of the third vaccination with FSME-IMMUN NEW
      in all volunteers who received both vaccinations in Baxter study 208 (safety study of FSME
      IMMUN NEW and ENCEPUR in healthy volunteers aged 16 to 65 years).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2002</start_date>
  <completion_date>August 2002</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>3973</enrollment>
  <condition>Encephalitis, Tick-borne</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Received two vaccinations during the course of Baxter study 208

          -  Understand the nature of the study, agree to its provisions and give written informed
             consent

          -  For volunteers under 18 years of age - written informed consent of the parents/legal
             guardian is given

        Exclusion Criteria:

        Volunteers assessed for eligibility to receive a third vaccination.

        Eligibility to receive third vaccination:

          -  ELISA value &gt; 126 VIE U/ml before the first TBE vaccination in Baxter study 208

          -  Not clinically healthy, (i.e. the physician would have reservations vaccinating with
             FSME-IMMUN NEW outside the scope of a clinical trial)

          -  Have already been administered a third TBE vaccination elsewhere since receiving the
             two vaccinations in Baxter study 208

          -  Have had an allergic reaction to one of the components of the vaccine since the last
             vaccination in Baxter study 208

          -  Suffer from a disease (e.g. autoimmune disease) or are undergoing a form of treatment
             (e.g. systemic corticosteroids, chemotherapeutics) that can be expected to influence
             immunological functions

          -  Have a known or suspected problem with drug or alcohol abuse (&gt; 4 liters wine / week
             or equivalent dose of other alcoholic beverages)

          -  Have received banked human blood or immunoglobulins within one month of study entry

          -  Are known to have become infected with HIV (a special HIV test is not required for the
             purpose of the study) since the last visit of study 208

          -  Have had a vaccination against yellow fever and / or Japanese B-encephalitis since the
             last visit in study 208

          -  Have received an investigational new drug within 6 weeks prior to study start

          -  Have a positive pregnancy test at the first medical examination (for females capable
             of bearing children)

          -  Do not agree to employ adequate birth control measures for the duration of the study
             (for females capable of bearing children)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>66 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerzy Romaszko, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PANTAMED sp. z o o.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jerzy Brzostek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zespol Opieki Zdrowotnej w Debicy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jerzy Dziduch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samodzielny Publiczny Zaklad Opieki Zdrowotnej Oddzial Pediatryczny</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Krystyna Jurowska, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Przedsiebiorstwo Uslug Medycznych &quot;Centrum Medyczne Nowa Huta&quot;</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marian Patrzalek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wojewodzki Szpital Dzieciecy Oddzial Obserwacyjno - Zakazny A</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Krzysztof Sladek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>&quot;Atopia&quot; Diagnostyka i Leczenie Chorob Alergicznych i Ukladu Oddechowego</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ryszard Konior</last_name>
    <role>Principal Investigator</role>
    <affiliation>Szpital Jana Pawla II Oddzial Neuoinfekcji</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Grazyna Zawada-Skrobisz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oddzial Chorob Zakaznych Specjalistyczny Szpital, Tarnow</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zespol Opieki Zdrowotnej w Debicy</name>
      <address>
        <city>Debica</city>
        <zip>33-200</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wojewodzki Szpital Dzieciecy Oddzial Obserwacyjno - Zakazny A</name>
      <address>
        <city>Kielce</city>
        <zip>25-381</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Atopia&quot; Diagnostyka i Leczenie Chorob Alergicznych i Ukladu Oddechowego</name>
      <address>
        <city>Krakow</city>
        <zip>30-018</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Przedsiebiorstwo Uslug Medycznych &quot;Centrum Medyczne Nowa Huta&quot;</name>
      <address>
        <city>Krakow</city>
        <zip>30-969</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Jana Pawla II Oddzial Neuroinfekcji</name>
      <address>
        <city>Krakow</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Zaklad Opieki Zdrowotnej Oddzial Pediatryczny</name>
      <address>
        <city>Lubartow</city>
        <zip>21-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PANTAMED sp. z o.o.</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-461</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oddzial Chor√≥b Zakaznych Specjalistyczny Szpital im. E. Szczeklika</name>
      <address>
        <city>Tarnow</city>
        <zip>33-100</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2005</study_first_posted>
  <last_update_submitted>May 20, 2015</last_update_submitted>
  <last_update_submitted_qc>May 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <keyword>tick-borne encephalitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Encephalitis</mesh_term>
    <mesh_term>Encephalitis, Tick-Borne</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

